Etiology of nosocomial infections and the susceptibility of nosocomial pathogens to imipenem and other antimicrobial agents at a tertiary care referral hospital
Open Access
- 31 August 1995
- journal article
- Published by Elsevier in Current Therapeutic Research
- Vol. 56 (8) , 746-755
- https://doi.org/10.1016/0011-393x(95)85058-9
Abstract
No abstract availableThis publication has 15 references indexed in Scilit:
- Imipenem/CilastatinDrugs, 1992
- Incidence of Beta-Lactamase Production among Out Patient Clinical Isolates in Middle Eastern Countries and Their Antibiotic SusceptibilitiesChemotherapy, 1992
- Antibiotic Resistance in Developing CountriesThe Journal of Infectious Diseases, 1985
- Increasing Resistance to Trimethoprim-Sulfamethoxazole Among Isolates of Escherichia coli in Developing CountriesThe Journal of Infectious Diseases, 1985
- Safety and efficacy of imipenem/cilastatin in treatment of complicated urinary tract infectionsThe American Journal of Medicine, 1985
- Efficacy of imipenem/cilastatin in endocarditisThe American Journal of Medicine, 1985
- Review of the in vitro spectrum of activity of imipenemThe American Journal of Medicine, 1985
- Emergence of Antibiotic Resistance In Hospitals, 1935-1975Clinical Infectious Diseases, 1979
- A critical appraisal of the importance of R-factors in the enterobacteriaceae in vivoJournal of Antimicrobial Chemotherapy, 1975
- Changing Ecology of Bacterial Infections as Related to Antibacterial TherapyThe Journal of Infectious Diseases, 1970